The recent deaths of children in India due to contaminated cough syrups have raised alarms about the country's drug safety regulations. In Madhya Pradesh, at least 19 children died after consuming a syrup containing diethylene glycol, a toxic substance. This incident follows previous tragedies, including the deaths of 70 children in The Gambia linked to Indian-made syrups. Critics point to a fragmented drug market and weak regulatory oversight as key issues. Cough syrups are often prescribed despite limited efficacy, with many parents turning to them out of desperation. The reliance on informal healthcare providers in rural areas exacerbates the problem, as these practitioners frequently lack formal training. Experts emphasize the need for better education among both healthcare providers and parents to reduce the reckless use of cough syrups and improve child health outcomes.